[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CME2)-P(H)PH)_TICL2]_RUCL2]
Compound with spectra: 1 NMR
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CME2)-P(H)PH)_TICL2]_RUCL2]](/api/compound/CVi11Q6R4sP.png?ph=true&h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CME2)-P(H)PH)_TICL2]_RUCL2]")
| SpectraBase Compound ID | CVi11Q6R4sP |
|---|---|
| InChI | InChI=1S/C14H14P.C10H13.C5H3.4ClH.Ru.Ti/c1-14(2,12-8-6-7-9-12)15-13-10-4-3-5-11-13;1-8(2)10-6-4-9(3)5-7-10;1-2-4-5-3-1;;;;;;/h3-8,10-11H,1-2H3;4,6-8H,1-3H3;1-2,5H;4*1H;;/q-1;;;;;;;+3;+2/p-4 |
| InChIKey | PSPKODWVDAFKED-UHFFFAOYSA-J |
| Mol Weight | 700.3 g/mol |
| Molecular Formula | C29H30Cl4PRuTi |
| Exact Mass | 698.936205 g/mol |
| Parent InChIKey | OQKHDJYMLHOBHA-UHFFFAOYSA-J |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,4-Epoxynaphthalene-6,6,7,7-tetracarbonitrile, 2,3-bis(chloromethyl)-1,2,3,4,5,8-hexahydro-5-methoxy-, (1.alpha.,2.alpha.,3.alpha.,4.alpha.,5.beta.)-
QUERCETAGETIN-6-O-BETA-D-GLUCOPYRANOSIDE
PICCONIOSIDE-V-PENTAACETATE
7-Methyl-2,3-diphenyl-1-(pyridin-2-yl)-1H-indole
1H-pyrazolo[4,3-c]quinoline, 3-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-8-methoxy-
1-acetyl-3-trifluoromethyl-4-phenyl-6-bromoquinolino[2,3-c]pyrazole
1,4-Methanocyclopropa[3,4]cyclopenta[1,2-c]furan-3(1H)-one, 5-(acetyloxy)hexahydro-1,4-dimethyl-, (1.alpha.,3a.beta.,3b.beta.,4.alpha.,4a.beta.,5.beta.,5a.beta.)-
(E)-1-HYDROXY-2-(3'-OXOBUT-1'-ENYL)-3,6,8-TRIACETOXYANTHRAQUINONE
1-(2,4-dichlorophenyl)-3-(3,4-dimethylphenyl)-1H-pyrazolo[4,3-c]quinoline
pyrano[2,3-c]pyrazole-5-carbonitrile, 6-amino-4-(6-bromo-1,3-benzodioxol-5-yl)-1,4-dihydro-3-(4-methoxyphenyl)-
| Title | Journal or Book | Year |
|---|---|---|
| Development of Bimetallic Titanocene−Ruthenium−Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties | Journal of Medicinal Chemistry | 2010 |